We describe a case of pulmonary embolism after sclerosant injection for bleeding oesophageal varices. The patient was managed successfully with enoxaparin. Systemic embolization after sclerotherapy is rare and depends upon a number of factors including the amount of sclerosant agent used. The incidence of this complication could be as high as 6% which warrants careful post procedure monitoring of patients.
Case report
A 56-year-old male was admitted with haematemesis & melaena. He had a background history of gastric ulcer, alcohol misuse, appendicectomy and shingles.
On examination he was tachycardic with blood pressure of 99/50 mmHg and respiratory rate of 14/ min. His oxygen saturation was 100% on 10 liters of O 2 . Clinical examination revealed no signs of chronic liver disease and melaena on per rectal gloved-finger examination. Initial labrotary investigations showed haemoglobin (Hb) of 9.1g/L, white cell count (WCC) 7.1x10 The patient continued to have melaena, although there was no further haematemesis. His Hb dropped further to 7.8 g/L and thrombocytopenia developed (PLT: 82x10 9 /L). He was transfused 3 units of red blood cells, 3 units of Fresh Frozen Plasma (FFP) and 1 unit of platelets. Oesophagogastroduodenoscopy (OGD) showed large oesophageal varices, which were banded and injected with sclerosant agent (sodium tetradecyl sulphate). Further management included intravenous glypressin and cephalosporin antibiotics. For twenty-four hours he remained haemodynamically stable with no further episodes of haematemesis or melaena. Abdominal ultrasound scan showed shrunken liver and enlarged spleen with moderate ascites; findings consistent with chronic liver disease with portal hypertension.
Thirty hours post-endoscopic therapy, the patient complained of acute onset right sided pleuritic chest pain. He was tachycardic and tachypnoeic and his oxygen saturation dropped to 82% on inhaled room air. The chest auscultation was otherwise normal. ECG showed atrial fibrillation with ventricular rate of 143/min. His PT sclerotherapy treatment for Pratesi P, Parra GG, Hita A variceal bleeding was 17 sec, APTT 26 sec and fibrinogen 4.00 g/L. A repeat chest x-ray showed atelectasis on both lung bases and bilateral small pleural effusions.
A CT pulmonary angiogram (Figure 1 ) confirmed suspected pulmonary embolism. The patient was started on enoxaparin. His further stay in the hospital was complicated by antibiotic related diarrhea. A repeat OGD showed grade 2 oesophageal varices (Figures 2, 3) and evidence of ulceration secondary to sclerotherapy. The patient was discharged home on proton pump inhibitor (PPI) and enoxaparin; he is currently waiting for his first follow-up clinic visit.
Discussion
Up to 30% of cirrhotic patients with portal hypertension will bleed from the upper gastrointestinal varices at 2 years; esophageal varices account for three-quarters of these bleeds. Sclerotherapy has been established as very effective and life-saving modality for the treatment of acute variceal bleed. Radiographically evident pulmonary embolisms (PE) are uncommonly observed following endoscopic sclerotherapy and it appears to be more common in patients receiving a higher volume of sclerosant agent (Table I) . [1] [2] [3] [4] [5] www.medigraphic.com
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Pulmonary Embolism as complication of scelrotherapy is thought to occur from the migration of the sclerosant into the pulmonary vasculature 5 causing an acute inflammatory reaction or chemical injury of the vessel wall resulting in an embolism. 6 In a retrospective study by Hwang et al., the volume of injected mixture was shown to be a predictor of embolisation. 6 Six out of 140 patients (4.3%) with pulmonary emboli were given a mean volume of more than 4.2 mL as opposed to 1.8 mL for those without pulmonary emboli. Four of these six patients had respiratory symptoms, although there were no direct deaths as a result of pulmonary embolization. Other factors implicated are the area injected and the use of repeated injections. 
